Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis - Wikidata - awgldk - TriplyDB

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

http://www.wikidata.org/entity/Q28168182

about

Aspirin as adjunctive treatment for giant cell arteritis Aspirin as adjunctive treatment for giant cell arteritis Inflammatory diseases of the aorta Disruption of a Regulatory Network Consisting of Neutrophils and Platelets Fosters Persisting Inflammation in Rheumatic Diseases Neuro-Ophthalmological Emergencies Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update Giant cell arteritis: a review.The thromboembolic risk in giant cell arteritis: a critical review of the literature.Diagnosis and treatment of cerebral vasculitis.Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.The treatment of giant cell arteritis Bilateral vertebral artery occlusion with retrograde basilary flow in three cases of giant cell arteritis.Balloon angioplasty of arteries of the upper extremities in patients with extracranial giant-cell arteritis Giant cell arteritis: Current treatment and management.Venous Thromboembolism and Cerebrovascular Events in Patients with Giant Cell Arteritis: A Population-Based Retrospective Cohort Study.Extra- and intracranial cerebral vasculitis in giant cell arteritis: an observational study.Risk factors for early visual deterioration in temporal arteritis.Fatal aortic dissection in a patient with giant cell arteritis: a case report and review of the literature Giant cell arteritis: a multicenter observational study in Brazil.Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.The diagnosis and treatment of giant cell arteritis.Giant cell arteritis: a systemic vascular disease.Thromboembolic disease in vasculitis.Translational mini-review series on immunology of vascular disease: mechanisms of vascular inflammation and remodelling in systemic vasculitis.Pharmacotherapy of vasculitis.An approach to the diagnosis and management of systemic vasculitis.Current understanding and management of giant cell arteritis and polymyalgia rheumatica.Headache and temporal arteritis: when to suspect and how to manage.Clinical features of polymyalgia rheumatica and giant cell arteritis.Clinical diagnosis and management of large vessel vasculitis: giant cell arteritis.Treatment of Susac Syndrome.Treatment of giant-cell arteritis, a literature review.Standard and biological treatment in large vessel vasculitis: guidelines and current approaches.Antithrombotic therapy in aortic diseases: A narrative review.Giant Cell Arteritis - Beyond temporal artery biopsy and steroids.Visual loss and other cranial ischaemic complications in giant cell arteritis.Optimal management of giant cell arteritis and polymyalgia rheumatica.[Large vessel vasculitis].Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up.

P2860

Q24194497-C6B6D81D-BA1A-4919-B7CF-608265247D7E Q24198176-F0C89E64-A120-408A-B95D-31EDAC9F578D Q26740223-58E96BC5-2D37-430B-92DE-C7E8A8103962 Q26744644-D58A1E55-A84B-44D4-8A22-6EE1C90F0332 Q26783463-176BA1E5-B35B-432A-BA93-4F162A8C96DD Q28070137-653B68E1-9837-4B99-BD35-4D8C31BD10B6 Q33688189-E218D1B2-51A6-4558-9757-0CF71698CCB8 Q33745753-02521F0D-18D8-46BC-BF82-80EACF033C0B Q34156332-10E1465D-BC10-4E4D-9DC0-D3827E0FDB37 Q34205665-690E55D9-1EF8-4025-9527-E6BD9E5886D0 Q34377832-857FEB3F-45CC-4056-AE44-11DC791D9986 Q34461224-F55A5134-DDFF-4BD6-9427-FF90AB249CF3 Q34528180-23D39812-AD37-47CB-B656-929852F0C67F Q35637815-5AE00148-DB9E-49A3-A73A-4760819F87EE Q35746677-D3E9F244-D3D4-41C2-A11A-5B1B3ACC9902 Q35931060-5AE5DE8E-67EB-4931-90BD-08B243F5BA4B Q36154063-2EBB2B56-99EB-45C4-959C-F809BC5C6A61 Q36226768-C2362155-F9E5-4625-B4D9-45F100B34B9D Q36692409-A030FAD5-F266-42A1-9CD7-281964EDB0FC Q36727516-1A771AD8-1213-486D-BDFF-FDAFDB8A872A Q36843077-20E9B7A6-3934-4670-B153-1E31C870C533 Q36921249-B5FDFD53-07BF-4072-B754-946B246F7047 Q37204521-04E8C930-C0AE-466A-8DB5-FEBFE2F62118 Q37349105-FD9AFFE5-EB32-400A-B962-F849A7AED78C Q37421806-F6A5BADE-71DD-4CA9-8D0B-BDD3BFE19677 Q37483910-10755048-1DEC-4E99-B7B4-7869C0EA3DCF Q37673239-74CE511A-0C7F-4C6D-B9AB-1392285520D6 Q37803414-253E7675-5F9A-40C7-9385-47D94F439279 Q38007105-ADE386B6-99A2-4B2C-96FF-4223BAF74307 Q38028863-1DDA0F31-9EFF-4A82-A30D-23DB4CD2E53F Q38217341-7D2B54EA-41E0-4453-90AA-9A60D1106035 Q38926836-0D4EBCFF-A12D-467B-91A1-6C7ED0371993 Q39029638-10C9255F-D611-4157-AC24-C64F3D278762 Q39100312-75FBD87C-784E-4009-A4E3-EC11F76FC496 Q39142382-0609ED06-F555-4BF4-B801-9A0460499A49 Q39293033-419E3F06-8D03-4B03-8796-D2AE41EA4426 Q39416333-21FC0A58-8191-4959-9E89-1C9DE41F97B8 Q39622832-521BAC3E-10D5-4FFB-AC6A-84CC5A21795B Q40203869-E5BA9CA8-591A-4214-ABF9-5657A8672C85 Q42138861-3B5C0BC5-5256-429A-B17F-E930418C60F8

P2860

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

http://www.wikidata.org/entity/Q28168182

description

2004 nî lūn-bûn

@nan

2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@ast

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@en

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@nl

type

label

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@ast

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@en

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@nl

prefLabel

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@ast

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@en

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@nl

P1433

Q28168182-1A174A53-E526-4CE8-A86A-05ED125F3C97

P1476

Q28168182-94B26A72-8048-43FD-87EB-EAA85C0CC743

P2093

Q28168182-00E4010E-2A7C-4794-9DEF-E65E4D029D2E

Q28168182-04637CB3-E149-44AC-B783-139A2FA9AB64

Q28168182-074F32C6-83CA-4DEE-80E3-C03D0379C3E7

Q28168182-4EBF828D-2EFC-4FFC-AFA6-4CE7540EA26F

Q28168182-8BE211E5-0686-48B7-AB04-01DEFA30AF0C

Q28168182-BA8898E8-5033-4D8B-BCCC-F92AEF53F7B3

P2860

Q28168182-0EEC43DA-82AC-422D-A0F5-F79C4E942C1B

Q28168182-801D68F3-5AE6-4313-8C2B-4C47F75CA24D

Q28168182-BF0EF91C-2ED7-484C-A8ED-B6D3F03AE4B3

Q28168182-EACCD2BD-F655-49C5-A2BA-F1CF018D053D

Q28168182-ECDFE79D-66FD-4515-8EBD-0FA9312153C4

P304

Q28168182-EE08730F-78E1-4068-A34A-B178F6D7FE3F

P31

Q28168182-3BF625B2-BAD1-4F2E-8BBB-6C142F2EF7AC

P3181

Q28168182-45BAF7F9-54B0-4296-BC97-9337F95061C8

P356

Q28168182-E0D9F415-7214-4AC7-9902-69B351C49151

P407

Q28168182-E4E1005E-EAA8-474E-9108-E2EBB4EA77FC

P433

Q28168182-573E4540-D660-4EAF-9FAD-D9F3E0E85FD4

P478

Q28168182-B18CE646-2546-4705-976A-F6218385BE37

P577

Q28168182-30B1DE98-D0ED-4E81-B4A0-A06C5A96AC4F

P5875

Q28168182-771A7CD9-3406-4B77-B6EC-32A5EE962A30

P698

Q28168182-BD59BCB7-42CF-4663-A08A-9B2C7BC6904A

P921

Q28168182-69956C60-7988-4307-BA20-1299DA527D3F

P3181

P356

P1433

Arthritis & Rheumatology

P1476

Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis

@en

P2093

Alan Rubinow

http://www.w3.org/2001/XMLSchema#string

Gideon Nesher

http://www.w3.org/2001/XMLSchema#string

Mario Baras

http://www.w3.org/2001/XMLSchema#string

Michal Mates

http://www.w3.org/2001/XMLSchema#string

Moshe Sonnenblick

http://www.w3.org/2001/XMLSchema#string

Yaakov Berkun

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence of nonarteritic anterior ischemic optic neuropathy.

Neurologic disease in biopsy-proven giant cell (temporal) arteritis.

Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision.

Progressive visual loss from giant cell arteritis despite high-dose intravenous methylprednisolone.

Ischemic optic neuropathy during corticosteroid therapy for giant cell arteritis.

P304

1332-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1331906

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ART.20171

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2004-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8625682

http://www.w3.org/2001/XMLSchema#string

P698

15077317

http://www.w3.org/2001/XMLSchema#string

P921